↓ Skip to main content

Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta- analysis

Overview of attention for article published in BMC Cancer, January 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
77 Dimensions

Readers on

mendeley
45 Mendeley
Title
Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta- analysis
Published in
BMC Cancer, January 2012
DOI 10.1186/1471-2407-12-17
Pubmed ID
Authors

Ying Zhou, Xin Yin, Jun Ying, BoHeng Zhang

Abstract

There have been conflicting reports about serum golgi protein 73 (GP73) as one of the most promising serum markers for the diagnosis of hepatocellular carcinoma (HCC). This study was to make a systematic review about the diagnostic accuracy of serum GP73 versus alpha-fetoprotein (AFP) for HCC.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 4%
United Kingdom 1 2%
Unknown 42 93%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 20%
Researcher 7 16%
Student > Postgraduate 6 13%
Student > Doctoral Student 5 11%
Student > Master 5 11%
Other 9 20%
Unknown 4 9%
Readers by discipline Count As %
Medicine and Dentistry 16 36%
Biochemistry, Genetics and Molecular Biology 6 13%
Agricultural and Biological Sciences 6 13%
Nursing and Health Professions 2 4%
Immunology and Microbiology 2 4%
Other 7 16%
Unknown 6 13%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 January 2012.
All research outputs
#18,303,566
of 22,661,413 outputs
Outputs from BMC Cancer
#5,417
of 8,239 outputs
Outputs of similar age
#196,051
of 245,660 outputs
Outputs of similar age from BMC Cancer
#55
of 75 outputs
Altmetric has tracked 22,661,413 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,239 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 21st percentile – i.e., 21% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 245,660 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 75 others from the same source and published within six weeks on either side of this one. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.